Neoadjuvant chemoimmunotherapy with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-2): an open-label, single-arm, phase 2 study.

albumin-bound paclitaxel - Generic mfg.

cisplatin - Generic mfg.

Tevimbra (tislelizumab-jsgr) - BeOne Medicines

Gilotrif (afatinib) - Boehringer Ingelheim

http://www.ncbi.nlm.nih.gov/pubmed/42731876

Dejuan Wang; Fei Chen; Feng Wang; Huaju Yang; Huijiao Chen; Jing Jin; Jun Liu; Leyu Li; Xingchen Peng; Yiqiao Luo; Yiyan Pei; Zhigong Wei

Sep 13, 2026